-

Global T Cell Immunotherapy Market Analysis, Trends, Market Size, and Forecasts up to 2026 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "T Cell Immunotherapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global T cell immunotherapy market to grow with a CAGR of 15.70% over the forecast period from 2020-2026.

The report on the global T-cell immunotherapy market provides qualitative and quantitative analysis for the period from 2018 to 2026. The study on the T-cell immunotherapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on the T-cell immunotherapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global T-cell immunotherapy market over the period of 2018 to 2026.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market, and opportunities for the new entrants in the global T cell immunotherapy market over the period of 2018 to 2026. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

What does this Report Deliver?

  • Comprehensive analysis of the global as well as regional markets of the T cell immunotherapy market.
  • Complete coverage of all the segments in the T cell immunotherapy market to analyze the trends, developments in the global market and forecast of market size up to 2026.
  • Comprehensive analysis of the companies operating in the global T cell immunotherapy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
  • Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Report Findings

1) Drivers

The growing occurrence of cancer in both children as well as in adults

2) Restraints

Extend waiting period for administration of t-cell immunotherapy is expected to hamper the market growth

3) Opportunities

The rapidly increasing research and development activities and technological advancement in cancer treatment

Segment Covered

The global T cell immunotherapy market is segmented on the basis of mechanism of action, type of therapy, and product class.

The Global T cell immunotherapy market by Mechanism of Action

  • Active Immunotherapy
  • Passive Immunotherapy

The Global T cell immunotherapy market by Type of Therapy

  • CAR-T
  • TCR
  • TIL

The Global T cell immunotherapy market by Product Class

  • Monoclonal Antibodies
  • Oncolytic Virus Therapy
  • Bispecific Antibodies
  • Cytokines

Company Profiles

  • Adaptimmune Therapeutics
  • Bluebird Bio
  • Innovative Cellular Therapeutics
  • Novartis
  • Sinobioway Cell Therapy
  • Cellectis
  • CARsgen Therapeutics
  • Autolus
  • Celgene

For more information about this report visit https://www.researchandmarkets.com/r/w5xosf

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

2-Day Advanced Veterinary Pharmacovigilance Online Training Course (May 21-22, 2026) with 12 CPD Hours - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Advanced Veterinary Pharmacovigilance Training Course (May 21st - May 22nd, 2026)" has been added to ResearchAndMarkets.com's offering. The purpose of this seminar is to provide a comprehensive, yet practical, assessment of the main requirements of Volume IXB, the new key document on pharmacovigilance guidelines used by the veterinary regulatory authorities to ensure a compliant reporting company. The programme will also consider the potential impact of Brexit on p...

3-Day Online Course: Clinical Research Project Management (April 29th to May 1st, 2026) - Boost Your Clinical Project Success with Agile Methodologies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Research Project Management Training Course (April 29, 2026 and May 1, 2026)" has been added to ResearchAndMarkets.com's offering. Setting up and running clinical research projects is a complex process that needs effective project management. The course includes an emphasis on the need to anticipate, understand, and implement detailed project management activities in a proactive manner. It is essential to manage clinical research projects within the set ti...

Drafting International Commercial Agreements in English: Online Training Course (May 11th-12th, 2026) with 12 CPD Hours - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Drafting International Commercial Agreements in English Training Course (May 11th - May 12th, 2026)" has been added to ResearchAndMarkets.com's offering. Most international agreements are drafted in the English language, irrespective of the nationality of the contracting parties. Language errors in the text and unclear and unconcise phrasing cause confusion and can ultimately lead to a dispute if they go unnoticed at the contract drafting stage. Under the careful g...
Back to Newsroom